Integra LifeSciences IART Europe — Total Revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's europe — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's europe — total revenues?
- Integra LifeSciences (IART) reported europe — total revenues of $39.96M in Q1 2026.
- How has Integra LifeSciences's europe — total revenues changed year-over-year?
- Integra LifeSciences's europe — total revenues increased by 13.1% year-over-year, from $35.33M to $39.96M.
- What is the long-term trend for Integra LifeSciences's europe — total revenues?
- Over 4 years (2021 to 2025), Integra LifeSciences's europe — total revenues has grown at a -4.0% compound annual growth rate (CAGR), from $191.33M to $162.67M.
- What does europe — total revenues mean?
- This metric represents the total net revenue generated from the sale of medical devices and regenerative technology products within the European geographic market. It serves as a key indicator of the company's regional market penetration and the demand for its specialty surgical and tissue technology portfolios. Tracking this figure allows investors to assess the performance and growth trajectory of the company's international operations outside of its domestic base.